A major review in Addiction synthesizes decades of evidence showing alcohol contributes to dozens of diseases and injuries across nearly every organ, weakens immune defenses and raises infection risk, and while some harms can lessen with reduced or stopped drinking, many damages persist; potential heart benefits of light drinking remain disputed.
In a 13-year study of 340,924 UK Biobank participants, low to moderate wine intake was associated with lower mortality risk than spirits, beer, or cider, including a 21% lower risk of cardiovascular death for moderate wine drinkers; even modest intake of spirits, beer, or cider linked to higher cardiovascular mortality. Heavy drinking raised death risk across beverage types. The findings may reflect wine’s polyphenols and healthier drinking patterns, but the study is observational and could be influenced by lifestyle factors, so randomized trials are needed for confirmation.
A large Australian study found that combining messaging that alcohol causes cancer with a simple action—counting every drink—most effectively reduced alcohol consumption over six weeks, outperforming other approaches. While results may not generalize everywhere, the findings support using cancer-risk information paired with actionable steps in public health education to curb drinking and its health risks.
A UK-based Oxford Longevity Project report argues that individuals bear at least 80% of ill health in old age and urges stronger government action on lifestyle factors such as alcohol; critics warn the claim oversimplifies health determinants like poverty and access to care, while supporters cite large-scale data showing environment and habits markedly influence aging and premature death. The report recommends avoiding processed foods, abstaining from alcohol, prioritizing sleep, and not eating after 6:30 pm.
A new review in Addiction confirms that alcohol causes more than 60 diseases and injuries that are entirely attributable to consumption, raises infection risk, and is linked to five broad non-communicable disease categories (cancer, cardiovascular disease, type 2 diabetes, neuropsychiatric, and gastrointestinal diseases). Some short‑term harms and certain cardiovascular markers can improve with abstinence, but chronic damage such as cirrhosis and much brain injury are not fully reversible, leading to the conclusion that alcohol’s overall harms outweigh any potential benefits (with evidence for heart protection at low intake remaining inconclusive).
A Johns Hopkins Medicine study shows that consuming cannabis edibles with alcohol produces greater and longer-lasting driving impairment than either substance alone, and standard field sobriety tests often miss cannabis-related impairment, underscoring the need for better public awareness and detection tools as well as reexamination of the 0.08% alcohol limit when cannabis is involved.
A woman’s struggle with alcohol reveals gaps in harm-reduction, medical care, and Alcoholics Anonymous, underscoring a broader shift in how alcohol-use disorder is treated and prompting discussion of newer approaches.
MetALD—metabolic dysfunction and alcohol-associated liver disease—is a rising U.S. health concern as obesity and diabetes intersect with heavy drinking. It affects people with liver fat and metabolic risk factors who drink more than 10 drinks per week (women) or 15 (men); the share of Americans meeting these criteria has roughly doubled since 1990, with about 1 in 10 adults reporting overlapping heavy drinking and obesity. Doctors warn many cases may go undetected, particularly among younger people and women.
The Bahamas will suspend alcohol sales onshore during the election on May 12 from 8 a.m. to 6 p.m., affecting all islands including CocoCay. Alcohol will still be sold aboard ships, but shore visits for cruise passengers will be dry. Royal Caribbean says it will comply with local laws, while some travelers vent on social media about the timing and impact on itineraries as ships visit Bahamian ports like CocoCay.
Gallup data show US alcohol consumption hitting an 85-year low in 2025, with 54% of Americans reporting they drink and abstention rising across demographics (notably women, youth, and lower-income groups). A majority—53%—now say moderate drinking is bad for health, and among drinkers the average is 2.8 drinks per week, signaling a broad health-driven shift away from alcohol.
A small study of 45 healthy adults found that even moderate alcohol use is linked to reduced brain blood flow, with stronger effects in older participants and in frontal/temporal regions tied to thinking and language. The findings suggest potential cognitive implications but come from a limited, observational sample, so researchers call for larger studies before any guideline changes.
A Danish randomized trial of 108 obese adults with alcohol use disorder found that 26 weeks of 2.4 mg semaglutide (Wegovy) reduced heavy drinking days from 17 to about 5 per 30 days and cut total alcohol intake from roughly 2,200 g to 650 g, suggesting GLP-1 therapies could complement treatments for alcohol use disorder alongside weight management.
A study in the Journal of Agricultural and Food Chemistry found beer contains measurable vitamin B6, but the amounts are modest and do not justify health-boosting claims; typical servings provide only a fraction to a minority of daily B6 needs, and there’s no evidence of brain benefits. Foods like potatoes, legumes, and fortified cereals supply B6 safely and more reliably. When accounting for alcohol’s well-established risks (liver disease, cancer) and methodological issues in observational data, any potential benefits are small at best. Media framing and marketing can mislead, underscoring that moderation or avoidance remains the safer public health stance.
A US study of 45 healthy adults links higher alcohol intake—even within what’s considered low levels (≤60 drinks/mo for men, ≤30 for women)—to reduced brain perfusion and thinner cortex, with brain blood flow showing a stronger association than cortical thickness. While not proving causation, the findings imply cumulative brain effects from low-level drinking and align with calls to re-evaluate “safe” drinking guidelines; self-reported intake and cross-sectional design limit conclusions. The study adds to growing evidence that even modest drinking may impact brain health, published in Alcohol (2026).
A study published in Alcohol finds that even low-level alcohol use over a lifetime, especially as people age, is associated with reduced cerebral blood flow and thinner cortex in multiple brain regions. An MRI analysis of 45 healthy adults (with 27 undergoing perfusion scans) showed that greater lifetime drinking and older age together correlated with lower blood flow across the cortex and thinner cortical tissue, notably in the frontal, parietal, and occipital lobes. The researchers suggest oxidative stress could contribute to these changes, but caution that small sample size, limited female representation, and unmeasured lifestyle factors limit conclusions and call for replication and evaluation of real-world functional effects like balance and dexterity before revising low-risk drinking guidelines.